Lynn Fussner is a Respiratory physician affiliated with The Ohio State University Wexner Medical Center. OpenAlex indexes 66 publications with 1,231 citations (h-index 13).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
181 Taylor Ave
Columbus, OH 432031779
Telephone
614-257-3000Provider last certified this registry record 13 Jun 2025.
Industry payments
6 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Amgen Inc.Program year20252 payments
- AstraZeneca Pharmaceuticals LPProgram year20251 payment
- Regeneron Healthcare Solutions, Inc.Program year20251 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
38.3%Short-acting sulfonamides25.4%Sulfamethoxazole-Trimethoprim100%Part D≥15 patientsMacrolide Antimicrobial7.6%Azithromycin100%Part D<11 patients+ 1 more class in this area
Respiratory
30%Corticosteroid17.8%Breo Ellipta28%Pulmicort Flexhaler26%Budesonide-Formoterol Fumarate24%Symbicort22%Part D<11 patientsbeta2-Adrenergic Agonist8.3%Albuterol Sulfate Hfa100%Part D≥13 patients+ 1 more class in this area
Metabolism & gastrointestinal
23.1%Corticosteroid17.8%Prednisone100%Part D<11 patientsProton pump inhibitor5.3%Omeprazole100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2024–2026 per NIH RePORTER. The latest:
- Novel role of alpha-1 antitrypsin in monocyte-driven disease activity in ANCA-associated vasculitis
Ohio State University
FY2026$190,620K23HL168328 - Novel role of alpha-1 antitrypsin in monocyte-driven disease activity in ANCA-associated vasculitis
Ohio State University
FY2025$190,620K23HL168328 - Novel role of alpha-1 antitrypsin in monocyte-driven disease activity in ANCA-associated vasculitis
Ohio State University
FY2024$190,620K23HL168328
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Heterogeneous causes of acute respiratory distress syndrome correlate with distinct peripheral polyunsaturated fatty acid metabolites
bioRxiv (Cold Spring Harbor Laboratory)
2026 - Cytokine profile of bronchoalveolar lavage in patients with and without checkpoint inhibitor pneumonitis
Cancer Immunology Immunotherapy
2025 - Palliative Care Referral Patterns and Outcomes for Patients with End-Stage Liver Disease at an Academic Liver Transplant Center
Journal of Palliative Medicine
2025
Similar KOLs
Other experts from the same institution or the same specialty.
Timothy Pawlik, MD
The Ohio State University Wexner Medical Center
Colleen Cebulla, MD
The Ohio State University Wexner Medical Center
Michael Grever, MD
The Ohio State University Wexner Medical Center
Brad Rovin, MD
The Ohio State University Wexner Medical Center
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”